For a hospital billing department, a denied insurance claim is more than a line item. It is a starting gun for a race against a clock, a manual process of poring over clinical notes, coding guidelines, and payer policies to craft a compliant appeal. The scale of the problem is staggering, with an estimated $260 billion in inpatient claims denied to American hospital systems annually [PMC]. Aegis, a seed-stage startup from Y Combinator's Spring 2025 batch, is betting that this race can be run by an AI.
The company's platform is designed to automate the end-to-end appeals workflow. It integrates with electronic health records and payer portals to detect denials, generate and submit compliant appeal letters, and track outcomes [Y Combinator, Spring 2025]. The ambition is not just to recover lost revenue for providers, but to free up clinical and administrative staff from what is often a frustrating, low-yield paper chase. For Pulse Raman, the patient outcome buried in that administrative sludge is the real story: delayed or denied appeals can mean delayed treatments and mounting financial toxicity for individuals.
The Wedge in a $300 Billion Bottleneck
The market Aegis is entering is not a green field. It is a well-documented, grinding bottleneck in healthcare economics, often cited as a $300 billion problem tied to billing complexity [Forbes, Aug 2025]. The startup's wedge is specificity. Rather than building another broad revenue cycle management suite, it focuses narrowly on the appeals process after a denial has occurred. This is a high-stakes, document-intensive task where speed and accuracy directly correlate with recovery rates. The founders argue that large language models, trained on medical guidelines and historical appeal data, can prioritize high-value denials and draft contextually appropriate appeals faster than human teams [Y Combinator, Spring 2025]. The early traction signal is a reported $440,000 in revenue generated by a four-person team in 2025 [GetLatka].
A Technical Team Learning Healthcare
The founding trio of Krishang Todi, Aarav Bajaj, and Dhanya Shah are close friends from Carnegie Mellon University, bringing complementary technical skills but no prior deep healthcare operating experience. Their backgrounds suggest a deliberate assembly of capabilities for this problem.
| Founder | Role | Background |
|---|---|---|
| Krishang Todi | CEO | Economics/Mathematics; fixed-income risk modeling at an Indian fund [Y Combinator, Spring 2025]. |
| Aarav Bajaj | Co-Founder | Computer Science/ML; former Palantir engineer and AI researcher at CMU [Y Combinator, Spring 2025]. |
| Dhanya Shah | COO | Information Systems/CS; seasoned full-stack engineer [Y Combinator, Spring 2025]. |
This is a classic Y Combinator pattern: sharp technical founders applying a novel technology wedge to a massive, known market. The risk modeling and machine learning expertise are directly relevant to parsing denial reasons and predicting appeal success. The missing piece is domain credibility within hospital CFO offices, which the team will need to build through early pilot customers and potentially a key commercial hire.
The Regulatory and Competitive Gauntlet
The path forward is fraught with challenges that go beyond typical software sales. Aegis operates in a heavily regulated environment where an incorrectly generated appeal could have compliance implications. The platform's ability to integrate deeply and securely with legacy EHR systems like Epic and Cerner will be a major technical hurdle and a key buying criterion. Furthermore, while no direct competitors are named in the sources, the startup is entering a space crowded with established revenue cycle management giants and a growing number of AI-enabled coding and billing assistants. Its success hinges on proving a superior return on investment specifically for the appeals function, which may require demonstrating outcomes through peer-reviewed studies or significant case studies.
The company's early metrics and YC backing provide a launchpad, but the next twelve months will be critical. The key signals to watch will be the signing of a first named hospital system customer, the publication of any third-party validation of its appeal win rates, and the expansion of the team with healthcare revenue cycle leadership. Another seed or Series A round will likely be necessary to fund the enterprise sales motion and continued product development required to cross the chasm from early adopters to the mainstream market.
For patients with complex conditions like cancer or rare diseases, the standard of care today often involves a parallel battle for financial clearance. A denied claim for a critical imaging scan or a targeted therapy can lead to weeks of back-and-forth between provider and payer, during which treatment may be postponed. The administrative burden falls on hospital staff, but the human cost is borne by the patient. Aegis is ultimately betting that by automating the appeal, it can accelerate the resolution of these financial barriers, ensuring the clinical pathway is not obstructed by paperwork. It is a humane angle on a profoundly inhumane system.
Sources
- [Forbes, Aug 2025] Healthcare’s $300 Billion Bottleneck: Why Billing Is The Next Big AI Battleground | https://www.forbes.com/councils/forbestechcouncil/2025/08/25/healthcares-300-billion-bottleneck-why-billing-is-the-next-big-ai-battleground/
- [GetLatka] Revenue metric for Aegis
- [PMC] American hospitals are denied about $260 billion per year in inpatient claims
- [Y Combinator, Spring 2025] Aegis: AI Agents to win denied health insurance claims | https://www.ycombinator.com/companies/aegis
- [Y Combinator, Spring 2025] Aegis AI Revenue Recovery Engine for Healthcare Providers | https://www.ycombinator.com/launches/NZg-aegis-ai-revenue-recovery-engine-for-healthcare-providers